Medication Therapy Management

This section contains information related to Part D Medication Therapy Management (MTM) Program requirements and information.

Requirements for Medication Therapy Management (MTM) Programs: Under 423.153(d), a Part D sponsor must have established a MTM program that:

• Ensures optimum therapeutic outcomes for targeted beneficiaries through improved medication use
• Reduces the risk of adverse events
• Is developed in cooperation with licensed and practicing pharmacists and physicians
• Describes the resources and time required to implement the program if using outside personnel and establishes the fees for pharmacists or others
• May be furnished by pharmacists or other qualified providers
• May distinguish between services in ambulatory and institutional settings
• Is coordinated with any care management plan established for a targeted individual under a chronic care improvement program (CCIP)

Each Part D Sponsor is required to incorporate a Medication Therapy Management (MTM) Program into their plans' benefit structure.  Annually, Sponsors must submit a MTM Program description to CMS for review and approval.  A CMS-approved MTM Program is one of several required elements in the development of a Sponsor's bid for the upcoming contract year.